article_metadata: Hongxiang Ji Zhijian Wen Bin Liu Hongbiao Chen Qian Lin Zhan Chen
article_metadata: 10.3389/fimmu.2022.995121
article_metadata: Front Immunol
article_metadata: 2022 Aug 26;13:995121.
article_metadata: ici-associated myocarditis (iciam) hepatocellular carcinoma (hcc) immune checkpoint inhibitor-associated adverse reactions (iraes) programmed cell death receptor 1/ligand 1 (pd-1/pd-l1) sintilimab
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/36091070/
article_metadata: Carcinoma, Hepatocellular / drug therapy Liver Neoplasms / drug therapy Myocarditis
article_metadata: Carcinoma, Hepatocellular / drug therapy Liver Neoplasms / drug therapy Myocarditis Case Reports Research Support, Non-U.S. Gov't Antibodies, Monoclonal, Humanized / adverse effects Humans Antibodies, Monoclonal, Humanized sintilimab
article_metadata: PMC9458972
article_metadata: 36091070
article_metadata: Sintilimab induced ICIAM in the treatment of advanced HCC: A case report and analysis of research progress
article_metadata: 2022